Feasibility and Safety of Taxane-PIPAC in Patients with Peritoneal Malignancies-a Retrospective Bi-institutional Study.

Mehta, Sanket; Kammar, Praveen; Patel, Ankita; Goswami, Gaurav; Shaikh, Sakina; Sukumar, Vivek; Trivedi, Esha; Bhatt, Aditi

Mehta, Sanket; Kammar, Praveen; Patel, Ankita; Goswami, Gaurav; Shaikh, Sakina; Sukumar, Vivek; Trivedi, Esha; Bhatt, Aditi.

Afiliación

Mehta S; Department of Surgical Oncology, Saifee Hospital, Mumbai, India.
Kammar P; Department of Surgical Oncology, Saifee Hospital, Mumbai, India.
Patel A; Department of Surgical Oncology, Zydus Hospital, Thaltej, Ahmedabad, 380054 India.
Goswami G; Department of Radiology, Zydus Hospital, Ahmedabad, India.
Shaikh S; Department of Surgical Oncology, Zydus Hospital, Thaltej, Ahmedabad, 380054 India.
Sukumar V; Department of Surgical Oncology, Saifee Hospital, Mumbai, India.
Trivedi E; Department of Surgical Oncology, Saifee Hospital, Mumbai, India.
Bhatt A; Department of Surgical Oncology, Zydus Hospital, Thaltej, Ahmedabad, 380054 India.

Indian J Surg Oncol ; : 1-9, 2022 Sep 07.

Article en En | MEDLINE | ID: mdl-36091624

Palabras clave

Docetaxel; PIPAC; Paclitaxel; Peritoneal metastases; Peritoneal surface malignancy; Taxanes

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Observational_studies Idioma: En Revista: Indian J Surg Oncol Año: 2022 Tipo del documento: Article País de afiliación: India

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google